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1. Introduction 
1.1 Background 
Epilepsy is not a single disease, but a broad group of conditions characterized by recurrent 
seizures resulting from the abnormal firing of cerebral neurons (1). Both medical and 
surgical treatments have been available for over a century, but there has been recent interest 
in radiosurgery as an alternative to open surgery for patients with medically intractable 
epilepsy. 
Mesial temporal lobe epilepsy (MTLE) specifically consists of atrophy and gliosis within the 
limbic system and is the most frequent cause of medically intractable epilepsy in adults (2). 
Currently, the standard treatment for epilepsy is the use of anticonvulsants. Medically 
intractable cases may be treated with temporal lobectomy, consisting of removal of parts of 
the superior temporal gyrus, temporal portion of the amygdala, and the hippocampus.  
Other causes of epilepsy include hypothalamic hamartomas (HH) and vascular 
malformations. Hypothalamic hamartomas are benign lesions composed of varying 
amounts of glia, neurons, and myelinated fibers. These tumors are often associated with 
gelastic seizures, precocious puberty, and behavioral problems (3) and often do not respond 
well to anticonvulsant therapy. As a result, surgical resection and stereotactic 
radiofrequency thermocoagulation have been used to treat HH (4). Epilepsy is also a 
symptom of cerebral vascular malformations. In particular, patients with cavernous 
malformations (CM) frequently present with drug-resistant epilepsy (5).  
Given the toxicity of open surgery and poor quality of life for patients with medically 
intractable epilepsy, stereotactic radiosurgery (SRS) with the Gamma Knife has been 
proposed as a viable alternative to open surgery for treating these patients. Preliminary data 
have shown that Gamma Knife radiosurgery is highly promising in terms of safety and 
efficacy for the treatment of MTLE (6-8). Potential advantages of Gamma Knife radiosurgery 
include lower morbidity and lower cost with equal effectiveness. One potential 
disadvantage of radiosurgery is the latency of response, which may be up to two years (9). 
Although much of the data are promising, the results of Vojtĕch et al suggest that more 
study is needed (10). Based on these data, an international clinical trial is currently being 
conducted for determining the role of radiosurgery for managing MTLE.  
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1.2 Radiosurgery for MTLE 
Because radiosurgery for MTLE is still an experimental procedure, a multi-center Phase III 
clinical trial known as the ROSE trial (Radiosurgery or Open Surgery for Epilepsy) was 
initiated in 2009 to investigate the use of Gamma Knife radiosurgery as an alternative to 
open surgery for the treatment of medically intractable mesial temporal lobe epilepsy (11, 
12). The primary objective of this study is to demonstrate the equivalence of radiosurgery 
with temporal lobectomy in terms of freedom from seizures. Other endpoints include 
quality of life, neuropsychological outcomes, and cost-effectiveness. 
Due to the location of the target volume and proximity of critical structures, Gamma Knife 
radiosurgery for mesial temporal lobe epilepsy (MTLE) is technically challenging. In this 
chapter we will discuss the methods used for planning Gamma Knife radiosurgery 
treatments for epilepsy, the equipment used for delivering these treatments, and challenges 
specific to the treatment of MTLE and other causes of epilepsy. 
Similar to the traditional surgical approach to treatment of MTLE with temporal lobectomy, 
the proposed radiosurgical treatment target is comprised of the amygdala, anterior 2 cm of 
the hippocampus, and the parahippocampal gyrus. Images of a representative target 
volume are shown in FIG. 1. The current target prescription dose is 24 Gy, which is based on 
the results of an earlier study in which lower doses were shown to result in reduced efficacy 
(13). The total irradiated volume is maintained to be less than 7.5 mL in order to minimize 
late radiation sequelae such as festering radiation necrosis. 
 
Fig. 1. (left) MR image showing target volume (red), brainstem (pink), and optical chiasm 
(blue). The target volume consists of the amygdala, anterior hippocampus, and 
parahippocampal gyrus. (right) A typical dose distribution is shown with the prescription 
(24 Gy) isodose line shown in yellow and the 8 Gy isodose line in green. 
1.3 Radiosurgery for hypothalamic harmatomas and cavernous malformations  
Studies have demonstrated that the use of stereotactic radiosurgery for treatment of epilepsy 
associated with hypothalamic hamartomas is safe and effective (14-22). In 2000, Régis et al 
reported the results of a multi-center study that involved ten patients treated at seven sites 
with Gamma Knife SRS (15). The median follow-up was 28 months and the results 
demonstrated a clear relationship between dose and efficacy and the authors recommended a 
margin dose of 18 Gy or more. Selch et al described the use of linac based SRS for the treatment 
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of HH (18). A good summary of the various treatment options for HH including SRS has been 
published by Régis et al (20). This report also includes the results of a prospective study of 
Gamma Knife SRS for hypothalamic hamartomas. At the time of publication, the authors had 
sufficient (3 years) follow-up to report results for 27 patients and found that a very good result 
was obtained in 60% of the patients.  
Data have also been published regarding the use of radiosurgery for treatment of epilepsy 
associated with cavernous malformations (23-28). In 1999, Bartolomei et al reported the 
results of a retrospective study to evaluate the feasibility of using radiosurgery to treat 
epilepsy associated with cavernous malformations (23, 29). Data from forty nine patients 
were included in this study, with over 70% either seizure-free or with a significant reduction  
 
Study Year No. of 
Patients
Findings
Hypothalamic Hamartomas 
Régis et al (15) 2000 10 40% patients were seizure free. 
Unger et al (16) 2002 4 No patients seizure free 
Barajas et al (17) 2005 3 No patients seizure free 
Selch et al (18) 2005 3 67% seizure free 
Matthieu et al (19) 2006 4 75% of patients showed improvement 
Régis et al (20) 2006 27 Very good result in 60% of patients. 
Abla et al (21) 2010 10 40% were seizure free after SRS. 
Mathieu et al (22)  2010 9 4/6 patients with smaller tumors seizure 
free. 0/3 with larger tumors seizure free. 
Cavernous Malformations   
Bartolomei et al (23) 1999 49 53% of patients seizure free. 
Kim et al (24) 2005 12 75% of patients seizure free 
Liscák et al (25) 2005 44 45% improved after radiosurgery 
Liu et al (26) 2005 28 53% reported good seizure control 
Shih and Pan (27) 2005 16 25% remained seizure free. 
Hsu et al (28) 2007 14 64% seizure free. Linac based radiosurgery. 
Mesial Temporal Lobe Epilepsy   
Régis et al (7) 1999 7 83% of patients were seizure free. 
Régis et al (6) 2004 20 65% were seizure free.  
Vojtech et al (10) 2009 14 18, 20, or 25 Gy. No seizure control 
achieved.  
Quigg et al (8) 2011 26 Patients received 20 or 24 Gy. No 
neuropsychological changes from baseline 
at 24 months. 
Table 1. Published Studies for Radiosurgical Treatment of Epilepsy Due to Various Causes. 
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in the number of seizures. Shih and Pan reported on 46 patients treated with surgery or 
radiosurgery for supratentorial cavernous malformations (27). Of this group, 24 of 46 
patients presented with seizures. The results suggested that patients undergoing craniotomy 
had better bleeding and seizure control than those receiving Gamma Knife radiosurgery.  
A brief summary of the literature regarding radiosurgical treatment of epilepsy due to 
various causes can be found in TABLE 1. We also refer the reader to the literature reviews 
on this topic by Quigg and Barbaro (2) and Romanelli et al (30). 
2. Methods and techniques 
2.1 Mesial temporal lobe epilepsy 
The dosimetric criteria for the ROSE trial included: 1) prescription dose of 24 Gy to the 50% 
isodose line (i.e., maximum dose of 48 Gy), 2) total volume receiving 24 Gy (V-24 Gy) within 
the range of 5.5-7.5 cm3, 3) maximum brainstem dose of 10 Gy, and 4) maximum dose of 8 
Gy to the optical apparatus.  
2.2 Hypothalamic hamartomas 
Planning for hypothalamic hamartomas is challenging due to the proximity of the brainstem 
and the optical apparatus (FIG. 2). However, compared to MTLE, planning for HH is less 
challenging due to lower doses and smaller target volumes for hypothalamic hamartomas. 
In our institution, target doses range from 15-18 Gy. Target volumes have ranged from 0.3 to 
2.1 cm3, with a mean volume of 0.81 cm3 (N=4).  
 
Fig. 2. Radiosurgery treatment for hypothalamic hamartoma. Note the proximity of the 
brainstem and the optical chiasm to the target volume. The prescription isodose line is 
shown in yellow and the 12 Gy isodose line in green. 
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2.3 Benchmarking treatment planning practices 
Due to the critical location of these lesions, special radiosurgical treatment planning 
techniques are applied to minimize the dose to the surrounding normal brain and functional 
structures. In order to achieve optimal dose fall-off outside of the target, it is preferable to 
use small collimators (i.e., 4-mm diameter) for treating such lesions. Selective blocking of 
individual beamlets is a must for enhancing the dose gradient toward a nearby critical 
structure. However, selective blocking and planning techniques are known to vary 
significantly among different Gamma Knife models and individual users. To benchmark 
such differences, a pre-clinical trial quality assurance procedure was developed. The results 
of such a study are summarized in the following section.  
3. Comparison among present gamma knife models for treating MTLE 
There are multiple models of the Leksell Gamma Knife currently in use. The newest is the 
Perfexion model introduced in 2006 (5-7). The Perfexion uses 192 Cobalt-60 sources (versus 
201 Cobalt-60 sources of prior Gamma Knife models) focused on a single point, the 
isocenter. The sources are arranged and divided conically into 8 sectors each containing 24 
sources. The sources can be collimated to form circular beams with a 4-mm, 8-mm, or 16-
mm diameter respectively or blocked entirely, with each sector being independently 
controlled, which is fundamentally different from previous models.  
By contrast, the previous model Gamma Knife (Model 4C) uses 201 Cobalt-60 sources. The 
sources are collimated to form circular beams with 4 mm, 8 mm, 14 mm, or 18 mm 
diameters. The collimator size is selected by switching helmets. All beams have the same 
diameter, but individual beams can be blocked by “plugging” the helmets. However, 
switching helmets and changing plugging patterns can be time consuming, so in reality only 
a limited number of plugging patterns are used. Despite these differences, the mechanical 
accuracy of all Gamma Knife models has been consistently maintained to be better than 0.4 
mm. As a result, Gamma Knife has so far been the only radiosurgical modality reported for 
managing intractable mesial temporal lobe epilepsy.  
As part of the physics review process for the ROSE trial, each center was required to submit 
a treatment plan based on a sample data set for the purpose of quality assurance. Image data 
for this sample patient were transferred to participating institutions. The target volume was 
then delineated and a treatment plan was created to satisfy the previously described 
dosimetric constraints. The plans were then transferred to the review center for a centralized 
review by the trial director. Plans that did not satisfy the dosimetric constraints were revised 
and resubmitted. Plans were submitted for the Gamma Knife Perfexion and C/4C models, 
depending on the device used at the individual centers. These data were analyzed to look 
for potential differences between the Perfexion and C/4C models.  
A total of 13 plans from 8 institutions satisfied the dosimetric constraints and were included 
in the data analysis. This included seven plans for the Model 4/4C and six plans for the 
Perfexion. Details of the individual plans are shown in TABLE 2.  
Parameters studied included beam-on time, number of shots, volume receiving 24 Gy (V-
24Gy), minimum dose to the delineated target, and the gradient index. Beam-on time was  
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Plan Institution Machine 
V-24Gy 
(cm3) 
Minimum 
dose (Gy) 
Beam-on 
Time (min)
No. of 
Shots 
Gradient 
Index 
1 1 4C 5.6 6.7 128 17 3.16 
2 2 4C 5.7 7.2 209 37 2.90 
3 2 4C 5.6 6.0 209 26 2.95 
4 3 4C 5.5 6.9 228 20 3.47 
5 4 4C 6.2 3.2 180 22 2.86 
6 4 4C 5.5 3.8 138 17 3.09 
7 5 4C 6.2 9.9 51 4 2.71 
All 4C  4C 5.8±0.3 6.2±2.2 163±62 20.4±10.0 3.0±0.2 
8 2 Pfxn 6.7 7.1 197 23 3.02 
9 6 Pfxn 7.5 5.2 158 17 2.93 
10 7 Pfxn 5.6 6.4 120 17 3.02 
11 2 Pfxn 5.5 7.0 246 26 2.96 
12 8 Pfxn 7.5 7.2 123 19 2.87 
13 8 Pfxn 7.4 8.7 88 12 2.95 
All Pfxn  Pfxn 6.7±0.9 6.9±1.1 155±58 19.0±4.9 3.0±0.1 
Table 2. Summary of Treatment Planning Results of a Single MLTE Case by 8 Individual 
Institutions. 
calculated assuming a dose rate of 3.0 Gy/minute. The gradient index was defined as the 
volume receiving the prescription dose (24 Gy) divided by the volume receiving half the 
prescription dose (12 Gy).(31) The Wilcoxon rank-sum test was employed to check for 
statistical significance. 
The average 24-Gy volume was larger for Perfexion plans as compared with Model 4/4C 
plans, suggesting more aggressive targeting of the treatment area while satisfying normal 
tissue constraints due to the added flexibility of the Perfexion. Plans created for the 
Perfexion tended to have a higher minimum dose to the target volume (FIG. 3), which is 
consistent with the above result. In addition, the results showed that the plans for the 
Perfexion tended to have shorter beam-on times (155±58 vs. 163±62) and used fewer shots 
(19±5 vs. 20±10). However the differences were not statistically significant due to the small 
sample size (FIG. 4). In particular, Plan 7 (for the 4C) used only four shots and had an 
extremely short beam-on time. After excluding Plan 7, the beam-on time and number of 
shots for the Model 4C increase to 182±41 minutes and 23±8 shots, respectively. The mean 
gradient index was 3.0 for both the Perfexion and the Model 4C.  
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Fig. 3. Boxplots showing the total volume receiving the prescription dose and the 
minimum dose received by the target. Differences were not statistically significant, 
although the results suggest that plans generated for the Perfexion provide better target 
coverage. 
 
Fig. 4. Comparison of the number of shots and beam-on time of treatment plans for the 
Gamma Knife Perfexion and Model 4C. Due to high variability in the results, differences are 
not statistically significant. However, the mean number of shots and mean beam-on time are 
lower for the Perfexion. 
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4. Summary 
Gamma Knife radiosurgery is being actively investigated as an alternative to open surgery 
for the treatment of MTLE and other forms of medically intractable epilepsy. Despite 
notable efficiency and practice differences between the various Gamma Knife models, 
consistent treatment planning practices and dosimetric parameters are demonstrated for a 
multi-institutional international trial setting. The final clinical results of such a trial for 
treating MTLE are forthcoming.  
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